ArticleBreathe (Sheffield, England)2026
Decoding the "black-box": explainable artificial intelligence towards trustworthy advancement in respiratory medicine.
Article in Breathe (Sheffield, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Bronchial Wall T2-Weighted MRI Signal: An Emerging Investigational Non-Ionizing Imaging Biomarker in Severe Asthma.Biomedicines · 2026Article
- Artificial Intelligence in Cardiovascular Ultrasound: Clinical Applications, Foundation Models, and the Path to Precision Cardiology.Journal of clinical medicine · 2026Review
- Thoracic ultrasound elastography in pleural and subpleural diseases: a narrative review.Journal of ultrasound · 2026Review
- Current Clinical Perspectives of Biomarkers in Respiratory Diseases: A Narrative Review.Journal of clinical medicine · 2026Review
- Artificial Intelligence-Induced Deskilling in Interventional Pulmonology: An International Cross-Sectional Survey on Risk Perception and Mitigation Strategies.Advances in respiratory medicine · 2026Observational
- The price of immune awakening: bridging knowledge gaps in checkpoint inhibitor-related pneumonitis in lung cancer.Breathe (Sheffield, England) · 2026Article
- Artificial intelligence for pleural effusion and pneumothorax detection on thoracic ultrasound: an educational viewpoint on the promise, pitfalls and path forward.Breathe (Sheffield, England) · 2026Article
- Highlights from the Italian National Congress of Imaging in Pulmonology 2025: fostering implementation of advanced technologies for precision patient-centered care.Multidisciplinary respiratory medicine · 2026Article
- Artificial Intelligence-Based Automated Analysis for Pleural Effusion Detection on Thoracic Ultrasound: A Systematic Review.Diagnostics (Basel, Switzerland) · 2026Review
- Artificial intelligence-assisted photodynamic diagnosis and photodynamic therapy against cancer.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is increasingly applied in respiratory medicine, offering potential advances in diagnostics, treatment guidance and patient monitoring. However, widespread clinical adoption remains limited due to the opaque "black-box" nature of many algorithms, which challenges clinicians' trust and hinders integration into routine practice. Explainable AI (XAI; methods and frameworks that render AI outputs interpretable and transparent) has emerged as a promising approach. By providing insights into algorithmic reasoning alongside predictive performance, XAI can support clinician evaluation, facilitate informed decision-making, and enhance accountability in patient care. This Viewpoint discusses the potential applications of XAI across respiratory medicine, highlighting its role in improving transparency, fostering clinician engagement and supporting integration of AI into clinical workflows. Beyond technical considerations, successful adoption of XAI requires cultural and educational shifts, including training programmes, interdisciplinary collaboration, patient engagement, and adherence to ethical and regulatory standards. XAI also holds potential in supporting shared decision-making, translating complex algorithmic outputs into understandable information for patients. By bridging advanced computational tools with clinical reasoning, XAI may help respiratory medicine move towards responsible, patient-centred and transparent AI implementation. Continued research, education, and collaboration are essential to realise its potential and ensure AI serves as a reliable partner in delivering high-quality respiratory care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.